OSL · MEDI.OL
Medistim ASA
NOK 307.00NOK 0.00 (0.0%)
Medistim ASA’s quoted price sits in the upper half of its reported 52-week range, 2.85% below the high.
Loading market information…
OSL · ABS.OL · NOK
Stock price, earnings
Quote as of Oct 30, 2026, 08:08 AM UTC. Cached market data; not a live quote.
One-year closing-price history · NOK. Historical prices are not a forecast.
Arctic Bioscience AS’s quoted price sits in the lower half of its reported 52-week range, 45.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Arctic Bioscience AS’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.
Latest available per-share figures in NOK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NOK 307.00NOK 0.00 (0.0%)
Medistim ASA’s quoted price sits in the upper half of its reported 52-week range, 2.85% below the high.
NOK 10.48-NOK 0.06 (-0.57%)
Circio Holding ASA’s quoted price sits in the upper half of its reported 52-week range, 33.25% below the high.
NOK 25.80NOK 0.00 (0.0%)
Nordhealth AS’s quoted price sits in the lower half of its reported 52-week range, 32.81% below the high.
NOK 4.15-NOK 0.07 (-1.54%)
Thor Medical ASA’s quoted price sits in the lower half of its reported 52-week range, 41.71% below the high.
NOK 46.20-NOK 0.50 (-1.07%)
Photocure ASA’s quoted price sits in the lower half of its reported 52-week range, 42.11% below the high.
NOK 21.40+NOK 1.40 (+7.0%)
Huddly AS’s quoted price sits in the lower half of its reported 52-week range, 40.56% below the high.
NOK 1.17NOK 0.00 (0.0%)
BerGenBio ASA’s quoted price sits in the lower half of its reported 52-week range, 92.54% below the high.
NOK 0.13+NOK 0.00 (+3.54%)
Airthings ASA’s quoted price sits in the lower half of its reported 52-week range, 94.02% below the high.
